Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 70 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9066855

    Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  2. US 9066943

    Use of botulinum toxin therapy for treatment of urological neurological conditions

    The Regents of the University of Colorado · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  3. US 9066965

    Purified limonin glucoside for prevention and treatment of chronic diseases

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  4. US 9060995

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  5. US 9061016

    Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

    APREA AB · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  6. US 9057104

    Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  7. US 9050343

    Combination of pimavanserin and risperidone for the treatment of psychosis

    ACADIA Pharmaceuticals Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  8. US 9050263

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  9. US 9051271

    Substituted pyridine derivatives useful in the treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  10. US 9050299

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  11. US 9044451

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  12. US 9034347

    Drug delivery system and method for the treatment of neuro-degenerative disease

    Arphios Corporation · Granted May 19, 2015 · Expires May 14, 2035

    granted

  13. US 9034923

    Methods for the treatment of senile dementia of the alzheimer's type

    Phenomenome Discoveries Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  14. US 9034318

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 19, 2015 · Expires May 14, 2035

    granted

  15. US 9034881

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  16. US 9028842

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Northwestern University · Granted May 12, 2015 · Expires May 7, 2035

    granted

  17. US 9029413

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 12, 2015 · Expires May 7, 2035

    granted

  18. US 9023356

    Treatment method using EGFR antibodies and SRC inhibitors and related formulations

    The Regents of the University of California · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  19. US 9018371

    Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  20. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  21. US 9018380

    Heterocyclic modulators of HIF activity for treatment of disease

    Boards of Regents, The University of Texas System · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  22. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  23. US 9011913

    Use of functionalized magnetic nanoparticles in cancer detection and treatment

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  24. US 9005599

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.